SmithKline Beecham, Novartis juggle executives
February 1st 1998BASEL, SWITZERLAND - Novartis Pharmaceuticals announced that Argeris "Jerry" Karabelas, former executive vice president of worldwide pharmaceuticals at SmithKline Beecham, is the new head of its global health care operations and CEO of its pharmaceuticals division.
European ban may pose threat to drug sales
February 1st 1998The European Union may pass a law that prohibits the import of medicines derived from sheep, goats and cattle, according to Jeffrey Trewhitt, vice president of communications for the Pharmaceutical Research and Manufacturers of America, Washington.
Report: Obesity growing into a heavy global problem
January 1st 1998The problem of obesity has grown dramatically during the 20th century and will escalate into what the World Health Organization has described as a pandemic unless people significantly change their diet and physical exercise habits, according to a new report from Datamonitor.
Zyban leads smoking-cessation market
January 1st 1998Zyban, a prescription smoking-cessation product launched by Glaxo Wellcome, Research Triangle Park, NC, last June, has muscled its way in front of its prescription and over-the-counter competitors, according to new data from Newton, PA-based Scott Levin.
Panel studies medication problems of elderly
January 1st 1998PHILADELPHIA - The American Society of Consultant Pharmacists will form an independent, interdisciplinary panel with the Alliance for Aging Research to examine medication-related problems in nursing facilities, the association announced at its annual meeting in November.